title: Probiotics: achieving a better regulatory fit.
abstract: The development and marketing of new probiotic products, substances containing live microorganisms that have a beneficial effect on the human body, have dramatically increased over the last few years. This article examines how the Food and Drug Administration and Federal Trade Commission currently regulate probiotics and makes recommendations as to changes that might be made to ensure that probiotic products are made available to the general public in a way that is both safe and effective.
authors.forename: Diane E
authors.initials: DE
authors.lastname: Hoffmann
authors.forename: Claire M
authors.initials: CM
authors.lastname: Fraser
authors.forename: Francis
authors.initials: F
authors.lastname: Palumbo
authors.forename: Jacques
authors.initials: J
authors.lastname: Ravel
authors.forename: Virginia
authors.initials: V
authors.lastname: Rowthorn
authors.forename: Jack
authors.initials: J
authors.lastname: Schwartz
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence; D019587:Dietary Supplements; D017277:Drug Approval; D005515:Food Labeling / Q000331:legislation & jurisprudence; D059022:Food Safety; D006293:Health Promotion; D006801:Humans; D007881:Legislation, Food; D064307:Microbiota; D009316:National Institutes of Health (U.S.); D019936:Probiotics; D014481:United States; D014486:United States Food and Drug Administration